Company / Shares Outstanding
Larimar Therapeutics, Inc. Shares Outstanding History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
37.3M
FY2019
5-year range
22.9M / 37.3M
FY2015-FY2019
Trend
+35.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 5 consecutive years, from 729391.00 in FY2014 to 37287221.00 in FY2019.
Based on SEC 10-K filings.
37287221.00 in FY2019 with a 5-year CAGR of +119.6%.
Increased from 27332551.00 to 37287221.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +11.0%
- 5-Year CAGR
- +119.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Larimar Therapeutics, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2019, shares outstanding increased 35.6% year-over-year.
- Lowest shares outstanding in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | 37.3M | +35.6% |
| FY2018 | 27.5M | +0.6% |
| FY2017 | 27.3M | +0.3% |
| FY2016 | 27.2M | +19.1% |
| FY2015 | 22.9M | +3036.7% |
| FY2014 | 729.4K | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026